Genomic Concordance Between Primary and Oligo‐Recurrent Lesions in Pancreatobiliary Cancer
Journal of Hepato-Biliary-Pancreatic Sciences · 2026-04 · 33 (4) · 322-329
DOI: 10.1002/jhbp.70065 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 19.01.2026. Verfasst von Keita Sonoda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoplasm Recurrence, Local, Bile Duct Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background/Purpose The introduction of oligo‐recurrence (OR) as a subtype of metastasis offered new hope, suggesting that local therapies may lead to prolonged survival/cure in selected cases. This study compared the genomic alterations between primary tumors and matched OR lesions in patients with pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA).
Methods
Eight patients with OR of PDAC or CCA were eligible. Genomic DNA was extracted from the tissue samples of primary tumors and matched OR lesions. Comprehensive genomic profiling (CGP) was performed using a panel of 216 cancer‐related genes. The genomic profiles of the two groups were compared.
Results
Among 17 tumor samples from eight patients, 32 genomic mutations were identified in nine genes. A total of 48 copy number alterations were found across 31 distinct genes. Driver genomic mutations were concordant between the primary tumors and OR lesions in all cases, whereas differences in passenger mutations were observed in two cases. Five of the eight patients remained recurrence‐free, including two pancreatic cancer cases who remained recurrence‐free for > 4 years after surgery.
Conclusions
The genomic mutation statuses of primary tumors and OR lesions were concordant, and patients' prognosis was significantly better than that of patients with other Stage IV cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
- Center for Cancer Genomics, Keio University School of Medicine, Tokyo, Japan.
- David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
ORCID-Profile: Keita Sonoda, Hideyuki Hayashi, Yasushi Hasegawa, Masayuki Tanaka
Zitieren
APA
Sonoda, K., Hayashi, H., Kitago, M., Abe, Y., Hasegawa, Y., Hori, S., Tanaka, M., Nakano, Y., Nishihara, H., & Kitagawa, Y. (2026). Genomic Concordance Between Primary and Oligo‐Recurrent Lesions in Pancreatobiliary Cancer. Journal of Hepato-Biliary-Pancreatic Sciences, 33(4), 322-329. https://doi.org/10.1002/jhbp.70065
Vancouver
Sonoda K, Hayashi H, Kitago M, Abe Y, Hasegawa Y, Hori S, et al. Genomic Concordance Between Primary and Oligo‐Recurrent Lesions in Pancreatobiliary Cancer. Journal of Hepato-Biliary-Pancreatic Sciences. 2026;33(4):322-329. doi:10.1002/jhbp.70065
BibTeX
@article{Sonoda2026,
author = {Sonoda, Keita and Hayashi, Hideyuki and Kitago, Minoru and Abe, Yuta and Hasegawa, Yasushi and Hori, Shutaro and Tanaka, Masayuki and Nakano, Yutaka and Nishihara, Hiroshi and Kitagawa, Yuko},
title = {Genomic Concordance Between Primary and Oligo‐Recurrent Lesions in Pancreatobiliary Cancer},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2026},
volume = {33},
number = {4},
pages = {322--329},
doi = {10.1002/jhbp.70065}
}
EUVIMED